Research summary, original research, 2019

Reduced radiation exposure in the cardiac catheterization laboratory with a novel vertical radiation shield

Panetta CJ, Galbraith EM, Yanavitski M, Koller PK, Shah B, Iqbal S, et al.. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions. 2019

Read the original paper

In plain language

In phantom tests and 177 cath lab procedures, adding a disposable vertical shield to standard shielding was associated with about 42% lower interventional cardiologist wrist dose. Wrist dosimetry only; not randomized and no health outcomes measured.

At a glance

Type of study
Original research, Prospective cohort study
Who was studied
Interventional cardiologists, Phantom or simulation (no people)
Size
n = 177 procedures
Summary based on
the full text

What it found

  • In clinical procedures with horizontal radiation absorbing pads, adding the vertical radiation shield lowered operator wrist dose by 41.9% with no difference in air kerma, and the difference persisted after multivariate adjustment.

    Key figures: 41.9% reduction (15.2 ± 13.4 vs. 26.2 ± 31.4 μSv, p = .001); adjusted p < .001

  • In phantom testing, VRS added to horizontal pads reduced mannequin dose rate by 59% in one lab and dose by 100% in a second lab.

    Key figures: 59% (p < .005); 100% (p = .016)

  • Combined HRAP and VRS reduced mannequin dose rate by 80% compared with no shielding in phantom model A.

    Key figures: 80% (p < .005)

  • Left anterior oblique (LAO)-caudal angulation produced the highest operator and patient exposure, two to four times other angles.

    Key figures: 2-4 times more radiation, p < .005

  • 8-inch magnification increased air kerma and operator dose rate versus 10-inch; moving 40 cm from the access site lowered operator dose rate by 30%.

    Key figures: +86.5% mGray, +12.2% μSv/min; -30% at 40 cm, -47% at 120 cm

Limits to keep in mind

Clinical comparison was non-randomized and unblinded with imbalanced groups (magnification, sex, fluoroscopy time), from one institution with four cardiologists; only wrist dose measured, not head or eye, and VRS tested at a single angle and magnification in phantoms.

How this summary was made

ORSIF prepared this summary with AI assistance from the full text of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.